$JSPR
Jasper Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$0.521
▼-2.09%-$0.011
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateJasper Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is JSPR down today? It is at $0.521 (-2.09%), and our scanner flagged it 15 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment JSPR spikes, and full due diligence on JSPR — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $JSPR 15 times in the last 30 days. Create a free account to track $JSPR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on JSPR from our scanner (live price and day move above). Fresh from the SEC: Jasper Therapeutics Announces Completion of. A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystClinical / FDA update, from the latest SEC filing. Read it →Across every filing on file, supply equal to 1359.8% of the tradeable float is in play - 1359.8% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
Active shelf on file — the company can issue new shares on demand (valid ~3 years)
At-the-market (ATM) program — sells new shares into the market gradually over time · About $132.0M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Shizuru Judith Anne Director | Bought (open market) | +41K 0.1% of company | added 35% | 157K | $100K at $2.43 | Sep 22, 25 |
Martell Ron Officer | Bought (open market) | +41K 0.1% of company | added 100% | 74K | $100K at $2.43 | Sep 22, 25 |
Lucas Svetlana Director | Bought (open market) | +20K 0.06% of company | n/a | 20K | $49K at $2.43 | Sep 22, 25 |
Wiggans Thomas G Director | Bought (open market) | +41K 0.1% of company | n/a | 41K | $100K at $2.43 | Sep 22, 25 |
Mahal Jeetinder Singh Officer | Sold (automatic/other) | -900 | sold 3.5% | 25K | $20K at $22.11 | Dec 12, 24 |
Mahal Jeetinder Singh Officer | Other | 900 | added 3.6% | 26K | $6K at $7.10 | Dec 12, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on JSPR from our scanner (live price and day move above). Fresh from the SEC: Jasper Therapeutics Announces Completion of. A material company disclosure like this is often the real catalyst behind a move of this size.
JSPR last traded at $0.521, down 2.09% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Jasper Therapeutics, Inc. Common Stock (JSPR) is next expected to report earnings on Monday, November 9, 2026, about 24 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The JSPR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged JSPR 15 times in the last 30 days.
JSPR (Jasper Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $18M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge JSPR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$JSPR discussion
Sign in to ask a question or join the discussion.